Markets & Regulations
Obesity drug slashes risk of heart attack or stroke ‘regardless of weight lost’
Trending
Sophie Anderson
A five-year trial investigated whether semaglutide, a drug currently sold under the brand names Ozempic, Wegovy and Rybelsus, could reduce the risk ...
